Literature DB >> 12691823

Number of pregnancies and ovariectomy modify mammary carcinoma development in transgenic HER-2/neu female mice.

Vladimir N Anisimov1, Irina G Popovich, Irina N Alimova, Mark A Zabezhinski, Anna V Semenchenko, Anatoli I Yashin.   

Abstract

We studied effect of pregnancy and ovariectomy on the development of mammary tumors in homozygous female HER-2/neutransgenic mice. The mean life span of uniparous mice was decreased by 16% in comparison to the control (P<0.05) and of mice which have two pregnancies decreased by 11% (P<0.05). Ovariectomy at the age of 2 months was followed by 32.7% increase in mean life span of mice. The incidence or multiplicity of mammary adenocarcinomas did not change in uniparous mice, whereas the size of the tumors and metastatic potential were decreased as compared to the virgins. When mice have two full-time pregnancies, there was an increase in multiplicity of mammary carcinomas and significant (2.1-fold) decrease in the survival time of tumor-bearing mice. Ovariectomy significantly decreased the total incidence of mammary carcinomas, the number of tumors per tumor-bearing animal, and inhibited metastasizing into lungs. Our results indicate that pregnancy accelerated the development of mammary adenocarcinomas in transgenic HER-2/neu mice whereas ovariectomy inhibits their development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691823     DOI: 10.1016/s0304-3835(02)00721-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.

Authors:  M D Landis; D D Seachrist; F W Abdul-Karim; R A Keri
Journal:  Oncogene       Date:  2006-01-23       Impact factor: 9.867

2.  Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesis.

Authors:  Michael J Toneff; Zhijun Du; Jie Dong; Jian Huang; Parisa Sinai; James Forman; Susan Hilsenbeck; Rachel Schiff; Shixia Huang; Yi Li
Journal:  Neoplasia       Date:  2010-09       Impact factor: 5.715

3.  Trisomy chromosome 5 is a recurrent cytogenetic lesion in mammary tumors from parous MMTV-erbB-2 transgenic mice.

Authors:  Young Mi Kim; Zhikun Ma; Seungjik Lee; Jiyun Lee; Shibo Li; Xiaohe Yang
Journal:  Oncol Lett       Date:  2011-08-04       Impact factor: 2.967

4.  Conditional mouse models demonstrate oncogene-dependent differences in tumor maintenance and recurrence.

Authors:  Maddalena T Tilli; Priscilla A Furth
Journal:  Breast Cancer Res       Date:  2003-05-30       Impact factor: 6.466

5.  Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in mice.

Authors:  M J Parsons; L McCormick; L Janke; A Howard; L Bouchier-Hayes; D R Green
Journal:  Cell Death Differ       Date:  2013-05-03       Impact factor: 15.828

6.  Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models.

Authors:  Lakshmanaswamy Rajkumar; Frances S Kittrell; Raphael C Guzman; Powel H Brown; Satyabrata Nandi; Daniel Medina
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

7.  Parabens and Human Epidermal Growth Factor Receptor Ligand Cross-Talk in Breast Cancer Cells.

Authors:  Shawn Pan; Chaoshen Yuan; Abderrahmane Tagmount; Ruthann A Rudel; Janet M Ackerman; Paul Yaswen; Chris D Vulpe; Dale C Leitman
Journal:  Environ Health Perspect       Date:  2015-10-27       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.